臨床試驗

Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer

NCT：NCT04396808 · ACTIVE_NOT_RECRUITING

NCT IDNCT04396808

狀態ACTIVE_NOT_RECRUITING

開始日期2020-11-05

SponsorUniversity of Michigan Rogel Cancer Center (OTHER)

First posted2020-05-21

Last updated2026-09-09

簡要摘要

This study seeks to determine the clinical impact of Gene Expression Classifier (GEC) testing in prostate cancer care while also developing a pragmatic approach for improved GEC clinical use and future study.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。